Home › Stocks › RPHM › All Fund Holders
RPHM — RENEO PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 24 · Reported value held: $18.88M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Franklin Resources history | Q3 2023 | 1.49M | $11.37M | 0.01% | Add |
| Invesco Ltd history | Q3 2023 | 449.36K | $3.42M | 0.00% | New |
| Vanguard Group history | Q3 2024 | 882.10K | $1.50M | 0.00% | Hold |
| Renaissance Technologies history | Q3 2024 | 501.53K | $852.61K | 0.00% | Add |
| BlackRock Inc history | Q3 2024 | 221.32K | $376.25K | 0.00% | New |
| Geode Capital Management history | Q3 2024 | 214.50K | $364.73K | 0.00% | Add |
| Two Sigma Investments history | Q3 2024 | 135.33K | $230.05K | 0.00% | Add |
| Millennium Management history | Q3 2024 | 120.56K | $204.96K | 0.00% | Add |
| Citadel Advisors history | Q3 2024 | 92.91K | $157.95K | 0.00% | Add |
| Morgan Stanley history | Q3 2024 | 64.52K | $109.69K | 0.00% | Reduce |
| Northern Trust Corp history | Q3 2024 | 44.01K | $74.82K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q1 2024 | 37.50K | $62.26K | 0.00% | Hold |
| BNY Mellon history | Q1 2024 | 34.23K | $56.81K | 0.00% | Reduce |
| Goldman Sachs Group history | Q3 2024 | 14.13K | $24.03K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2024 | 12.62K | $19.06K | 0.00% | Add |
| AQR Capital Management history | Q2 2024 | 10.40K | $15.71K | 0.00% | New |
| Deutsche Bank AG history | Q1 2022 | 4.72K | $14.00K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q3 2024 | 7.67K | $13.04K | 0.00% | Reduce |
| Citigroup Inc history | Q3 2024 | 3.55K | $6.04K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q1 2024 | 1.42K | $2.35K | 0.00% | Hold |
| Bank of America Corp history | Q3 2024 | 1.21K | $2.06K | 0.00% | Add |
| Wells Fargo & Co history | Q3 2024 | 1.20K | $2.04K | 0.00% | Hold |
| UBS Group AG history | Q3 2024 | 1.19K | $2.02K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2024 | 353 | $533 | 0.00% | Reduce |